SWK Holdings Corporation (SWKH)
| Market Cap | 228.16M |
| Revenue (ttm) | 38.81M |
| Net Income (ttm) | 13.25M |
| Shares Out | 12.80M |
| EPS (ttm) | 1.02 |
| PE Ratio | 17.32 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 29 |
| Last Price | $17.70 |
| Previous Close | $17.80 |
| Change ($) | -0.10 |
| Change (%) | -0.56% |
| Day's Open | 17.83 |
| Day's Range | 17.70 - 17.83 |
| Day's Volume | 1,014 |
| 52-Week Range | 12.28 - 18.00 |
DALLAS, July 19, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage...
DALLAS, June 23, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and mid-sized commercial-stage...
BOONTON, N.J., June 15, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsi...
DALLAS, June 11, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announ...
AL, FET, INO, SWKH, and WPG have been added to the Zacks Rank #5 (Strong Sell) List on June 7, 2021.
BOONTON, N.J., June 7, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsid...
DALLAS, May 17, 2021 /PRNewswire/ -- Corporate Updates YTD SWK has closed two financings totaling up to $14.0 million Enteris BioPharma subsidiary announced completion of manufacturing facility expansio...
DALLAS, May 17, 2021 /PRNewswire/ -- The Board of Directors (the "Board") of SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") and its controlling stockholder, funds affiliated with Carls...
Top Ranked Value Stocks to Buy for May 4th
BOONTON, N.J., May 3, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subsidi...
New Strong Buy Stocks for April 7th
DALLAS, April 6, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) (the "Company" or "SWK") confirmed that on April 5, 2021, a Special Committee (the "Special Committee") of the Company's Boa...
DALLAS, March 31, 2021 /PRNewswire/ -- Corporate Highlights Closed four transactions in 2020 deploying $34.8 million; additional $8.1 million deployed to existing borrowers Income producing assets as of...
POMPANO BEACH, Fla., March 24, 2021 /PRNewswire/ -- Sincerus Pharmaceuticals, the parent company of Prescriber's Choice and Sincerus Florida, today announced the completion of a major new round of growt...
BOONTON, N.J., March 16, 2021 /PRNewswire/ -- Enteris BioPharma, Inc., a biotechnology company developing innovative drug products based on its proprietary delivery technologies, and a wholly-owned subs...
DALLAS, March 15, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today annou...
SWKH vs. LU: Which Stock Is the Better Value Option?
DALLAS, Feb. 16, 2021 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today provide...
SWKH vs. RCM: Which Stock Is the Better Value Option?
MOUNT OLIVE, N.J., Jan. 4, 2021 /PRNewswire/ -- Flowonix Medical, Inc., a medical device company focused on providing advanced, implantable drug delivery solutions and SWK Holdings Corporation (Nasdaq: ...
DALLAS, Dec. 24, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announ...
DALLAS, Nov. 13, 2020 /PRNewswire/ -- Corporate Highlights Enteris BioPharma, Inc., ("Enteris") a wholly-owned subsidiary of SWK Holdings, recognized $2.5 million in milestone revenue under the license ...
DALLAS, Nov. 11, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Bl...
DALLAS, Oct. 27, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small- and mid-sized commercial-stage companies, today announ...
DALLAS, Sept. 15, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston B...
BOONTON, N.J., Sept. 15, 2020 /PRNewswire/ -- Enteris BioPharma, Inc.
DALLAS, Sept. 9, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, today announced that its chairman and chief executive officer, Winston Bl...
SWK Holdings Corporation (SWKH) CEO Winston Black on Q2 2020 Results - Earnings Call Transcript
DALLAS, Aug. 14, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced that the Company will host a conference call and live audio web...
DALLAS, June 23, 2020 /PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH), a life science focused specialty finance company, announced today that Chairman and CEO Winston Black will present via webc...
About SWKH
SWK Holdings Corporation, a specialty finance company, focuses on the healthcare sector. The company operates in two segments, Finance Receivables and Pharmaceutical Development. It provides customized financing solutions to a range of life science companies, including companies in the biotechnology, medical device, medical diagnostics and related tools, animal health, and pharmaceutical industries, as well as institutions and inventors. The company, through its subsidiary, SWK Advisors LLC, offers non-discretionary investment advisory services... [Read more...]
| Industry Asset Management | IPO Date Sep 22, 1999 |
| Stock Exchange NASDAQ | Ticker Symbol SWKH |
Financial Performance
In 2020, SWK Holdings's revenue was $36.71 million, an increase of 19.40% compared to the previous year's $30.75 million. Earnings were $5.20 million, a decrease of -78.17%.
Analyst Forecasts
According to 2 analysts, the average rating for SWK Holdings stock is "Buy." The 12-month stock price forecast is 29.50, which is an increase of 66.67% from the latest price.